Bleeding risk among cancer patients receiving concurrent CYP-interacting tyrosine kinase inhibitors with direct oral anticoagulants versus alternative anticoagulation therapies
Journal of Oncology Pharmacy Practice
Published online on August 19, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionCancer-associated stroke and venous thromboembolism (VTE) are common, life-threatening conditions in patients with cancer. Low-molecular-weight heparin was the standard of care for cancer-associated VTE, until recent evidence supported the ...
IntroductionCancer-associated stroke and venous thromboembolism (VTE) are common, life-threatening conditions in patients with cancer. Low-molecular-weight heparin was the standard of care for cancer-associated VTE, until recent evidence supported the ...